EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
Authors:
Open Access
- 1 July 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (13) , 4367-4377
Abstract
Purpose: Constitutive Wnt signaling caused by mutations in the β-catenin gene is a molecular hallmark of adamantinomatous craniopharyngiomas (adaCP) and promotes infiltration into adjacent brain tissue. Herein, we studied the pathogenic role of epidermal growth factor receptor (EGFR) activation in adaCP and whether tumor cell migration can be inhibited by the tyrosine kinase inhibitor gefitinib.Keywords
This publication has 37 references indexed in Scilit:
- Fascin: A key regulator of cytoskeletal dynamicsThe International Journal of Biochemistry & Cell Biology, 2010
- Epidermal growth factor receptor regulates β-catenin location, stability, and transcriptional activity in oral cancerMolecular Cancer, 2010
- Target Gene Activation of the Wnt Signaling Pathway in Nuclear β‐Catenin Accumulating Cells of Adamantinomatous CraniopharyngiomasBrain Pathology, 2009
- Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivoNeuro-Oncology, 2009
- Surgical management of giant craniopharyngiomasActa Neurochirurgica, 2008
- Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung CancerMolecular & Cellular Proteomics, 2008
- Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancersBMC Cancer, 2008
- Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control studyBMC Cancer, 2007
- CraniopharyngiomaOrphanet Journal of Rare Diseases, 2007
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004